Point of Care Diagnostics – Market Adoption and Technology Trends

SMi's 7th annual Point of Care Diagnostics will present you with an insight into the many challenges facing this industry and provide an unsurpassed opportunity to obtain information you need in order to remain competitive in this evolving market.
By: SMi Group Ltd
 
Sept. 1, 2010 - PRLog -- The point of care diagnostic testing market is forecast to expand from US$13.4 billion in 2008 to over US$22.5 billion in 2013 and comprise 25% of the total in vitro diagnostics market. Growth has been driven in part due to the promise of speed, convenience, and improved patient outcomes that point of care testing can bring.

Drawing on key opinion leaders in the field of POC Diagnostics, SMi's 7th Annual Point of Care Diagnostics: Market Adoption and Technology Trends on the 25th & 26th of October will present an insight into the many challenges facing this industry and provide an unsurpassed opportunity for you to obtain information you need in order to remain competitive in this evolving market.

For more information visit our website
http://www.smi-online.co.uk/10pointofcare41.asp

The conference will examine critical issues including:
Markets & Commercial Strategies: Understanding the drivers and barriers to PoC diagnostics adoption and competing in the evolving worldwide point of care diagnostics market
Reimbursement, Remuneration and Regulation: Updated guidance and cost effectiveness analyses
Technology & Connectivity: New technologies, personalised medicine and managing point of care diagnostics in a networked world

Key presentations include:
•   Picomolar sensitivty with a POC technology
Marsha Oenick, Director, Product Development, Ortho Clinical Diagnostics
•   Competing in the evolving worldwide POCT market
Harry Glorikian, Managing Partner, Scientia Advisors
•   Reimbursement and health technology appraisals
Paul Weinberger, President, Diagnostic Solutions
•   Predicting and planning for the POC market of the future
Thomas Raichle, Senior Director, Roche Diagnostics
•   The role of POCT in personalised medicine
Eddie Blair, Director, Integrated Medicines Ltd
•   Managing point-of-care testing in a networked world
Fabrizio Mastrantonio, International Marketing Manager, A Menarini Diagnostics

For more information visit our website
http://www.smi-online.co.uk/10pointofcare41.asp

# # #

SMi have had an established portfolio of Pharmaceutical, Defence, Energy, Finance and PPP/PFI events running since 1993. We are at the forefront of linking businesses with information, organising over 150 Conferences, Workshops and Masterclasses every year. All our events are research driven and highly targeted towards senior level professionals, designed to help you make informed decisions and remain at the cutting edge of business information
End
Source:SMi Group Ltd
Email:***@smi-online.co.uk Email Verified
Zip:SE1 0HS
Tags:Diagnostic, Test, Diabetes, Point Of Care, Pharma, Personalised Medicine, Pharmacy, Biochemist
Industry:Health, Science, Medical
Location:Southwark - London, Greater - England
Account Email Address Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share